المؤلفون: Vincenzo Adamo, Giuseppa Ferraro, Claudia Proto, Giuseppina Rosaria Rita Ricciardi

المصدر: Future oncology (London, England). 10(15)

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Standard of care, Disease Response, Breast Neoplasms, Antimitotic Agents, chemistry.chemical_compound, Breast cancer, Internal medicine, medicine, Humans, eribulin, heavily pretreated patient, metastatic breast cancer, Furans, business.industry, Eye Neoplasms, General Medicine, Ketones, Middle Aged, medicine.disease, Metastatic breast cancer, Disease control, Treatment Outcome, chemistry, Toxicity, Female, business, After treatment, Eribulin

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4704b874f38aa87f3494275a5963f8dd
https://pubmed.ncbi.nlm.nih.gov/25525850

المؤلفون: RICCIARDI, GIUSEPPINA ROSARIA, PROTO, CLAUDIA, FERRARO, Giuseppa, ADAMO, Vincenzo

المساهمون: Ricciardi, Giuseppina Rosaria Rita, Proto, Claudia, Ferraro, Giuseppa, Adamo, Vincenzo

مصطلحات موضوعية: eribulin, heavily pretreated patient, metastatic breast cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/25525850; info:eu-repo/semantics/altIdentifier/wos/WOS:000346652100011; volume:10; issue:15; firstpage:2417; lastpage:2422; numberofpages:6; journal:FUTURE ONCOLOGY; http://hdl.handle.net/11570/3057300; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84920030591

الاتاحة: http://hdl.handle.net/11570/3057300
https://doi.org/10.2217/fon.14.160